Production (Stage)
Labcorp Holdings Inc.
LH
$242.53
$0.640.27%
NYSE
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | 0.47% | 1.44% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 0.47% | 1.44% | |||
| Cost of Revenue | -1.48% | 2.33% | |||
| Gross Profit | 5.77% | -0.90% | |||
| SG&A Expenses | -8.27% | 4.68% | |||
| Depreciation & Amortization | -1.14% | 10.52% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -2.78% | 2.95% | |||
| Operating Income | 44.08% | -15.21% | |||
| Income Before Tax | 49.73% | -12.73% | |||
| Income Tax Expenses | 54.73% | -1.95% | |||
| Earnings from Continuing Operations | 48.33% | -15.33% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | 0.00% | 33.33% | |||
| Net Income | 48.40% | -15.30% | |||
| EBIT | 44.08% | -15.21% | |||
| EBITDA | 55.42% | -25.92% | |||
| EPS Basic | 48.40% | -14.89% | |||
| Normalized Basic EPS | 17.55% | 2.74% | |||
| EPS Diluted | 47.75% | -14.72% | |||
| Normalized Diluted EPS | 17.41% | 2.49% | |||
| Average Basic Shares Outstanding | 0.00% | -0.48% | |||
| Average Diluted Shares Outstanding | 0.12% | -0.24% | |||
| Dividend Per Share | 0.00% | 0.00% | |||
| Payout Ratio | -0.31% | 0.17% | |||